If the patient has both obesity and type 2 diabetes, the provider may be able to prescribe Ozempic for the diabetes indication, and the patient may experience weight loss as a secondary benefit
adults are classified as obese, resulting in an increased demand for OMMs
Metabolism 164:156113 Linge J, Birkenfeld AL, Neeland IJ (2024) Muscle mass and Glucagon-Like Peptide-1 receptor agonists: adaptive or maladaptive response to weight loss
Members of this family are responsible for responding to diverse extracellular cues, such as odorants, neurotransmitters, and hormones (such as adrenaline, which binds to adrenergic receptors)
GLP-1 medications are a safe and effective tool in weight management, but should be used under the supervision of your doctor.